Psychological stress alters the ultrastructure and increases IL-1β and TNF-α in mandibular condylar cartilage

Brazilian Journal of Medical and Biological Research

Volumn 45, Issue 10, 2012, Pages 968-976

  Lv, Xin ^a   Li, Qiang ^a   Wu, Shun ^a   Sun, Jing ^a   Zhang, Min ^a   Chen, Yong Jin ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

IL 1 ; Psychological stress; Temporomandibular joint; TNF

Indexed keywords

CORTICOSTERONE; EOSIN; HEMATOXYLIN; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARTILAGE DEGENERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOTSHOCK; HISTOLOGY; HORMONE DETERMINATION; JAW DISEASE; MALE; MANDIBLE CONDYLE; MENTAL STRESS; NONHUMAN; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; SPRAGUE DAWLEY RAT; TEMPOROMANDIBULAR JOINT; ULTRASTRUCTURE; UPREGULATION;

ANIMALIA; RATTUS;

ANIMALS; CARTILAGE; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; INTERLEUKIN-1BETA; MALE; MANDIBULAR CONDYLE; MICROSCOPY, ELECTRON, SCANNING; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STRESS, PSYCHOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84866030982     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2012007500102     Document Type: Article

References (36)

1. McNeill C, Mohl ND, Rugh JD, Tanaka TT. Temporomandibular disorders: diagnosis, management, education, and research. J Am Dent Assoc 1990; 120: 253, 255, 257.
2. Hagag G, Yoshida K, Miura H. Occlusion, prosthodontic treatment, and temporomandibular disorders: a review. J Med Dent Sci 2000; 47: 61-66.
3. Slade GD, Diatchenko L, Bhalang K, Sigurdsson A, Fillingim RB, Belfer I, et al. Influence of psychological factors on risk of temporomandibular disorders. J Dent Res 2007; 86: 1120-1125.
4. List T, Wahlund K, Larsson B. Psychosocial functioning and dental factors in adolescents with temporomandibular disorders: a case-control study. J Orofac Pain 2001; 15: 218-227.
5. Kafas P, Leeson R. Assessment of pain in temporomandibular disorders: the bio-psychosocial complexity. Int J Oral Maxillofac Surg 2006; 35: 145-149.
6. Lobbezoo F, Drangsholt M, Peck C, Sato H, Kopp S, Svens-son P. Topical review: new insights into the pathology and diagnosis of disorders of the temporomandibular joint. J Orofac Pain 2004; 18: 181-191.
7. Whiteside TL. Cytokine measurements and interpretation of cytokine assays in human disease. J Clin Immunol 1994; 14: 327-339.
8. Arend WP, Dayer JM. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990; 33: 305-315.
9. Pelletier JP, DiBattista JA, Roughley P, McCollum R, Martel-Pelletier J. Cytokines and inflammation in cartilage degradation. Rheum Dis Clin North Am 1993; 19: 545-568.
10. Takahashi T, Kondoh T, Fukuda M, Yamazaki Y, Toyosaki T, Suzuki R. Proinflammatory cytokines detectable in synovial fluids from patients with temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 85: 135-141.
11. Kaneyama K, Segami N, Sun W, Sato J, Fujimura K. Analysis of tumor necrosis factor-alpha, interleukin-6, interleukin-1beta, soluble tumor necrosis factor receptors I and II, interleukin-6 soluble receptor, interleukin-1 soluble receptor type II, interleukin-1 receptor antagonist, and protein in the synovial fluid of patients with temporomandibular joint disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 99: 276-284.
12. Dijkgraaf LC, de Bont LG, Boering G, Liem RS. The structure, biochemistry, and metabolism of osteoarthritic cartilage: a review of the literature. J Oral Maxillofac Surg 1995; 53: 1182-1192.
13. Cui R, Suemaru K, Li B, Araki H. The effects of atropine on changes in the sleep patterns induced by psychological stress in rats. Eur J Pharmacol 2008; 579: 153-159.
14. Rosales VP, Ikeda K, Hizaki K, Naruo T, Nozoe S, Ito G. Emotional stress and bruxlike activity of the masseter muscle in rats. Eur J Orthod 2002; 24: 107-117.
15. Zelena D, Domokos A, Barna I, Mergl Z, Haller J, Makara GB. Control of the hypothalamopituitary-adrenal axis in the neonatal period: adrenocorticotropin and corticosterone stress responses dissociate in vasopressin-deficient brattle-boro rats. Endocrinology 2008; 149: 2576-2583.
16. Turner JA, Mancl L, Aaron LA. Brief cognitive-behavioral therapy for temporomandibular disorder pain: effects on daily electronic outcome and process measures. Pain 2005; 117: 377-387.
17. Wright AR, Gatchel RJ, Wildenstein L, Riggs R, Buschang P, Ellis E III. Biopsychosocial differences between high-risk and low-risk patients with acute TMD-related pain. J Am Dent Assoc 2004; 135: 474-483.
18. Depke M, Fusch G, Domanska G, Geffers R, Volker U, Schuett C, et al. Hypermetabolic syndrome as a consequence of repeated psychological stress in mice. Endocrinology 2008; 149: 2714-2723.
19. Kiank C, Holtfreter B, Starke A, Mundt A, Wilke C, Schutt C. Stress susceptibility predicts the severity of immune depression and the failure to combat bacterial infections in chronically stressed mice. Brain Behav Immun 2006; 20: 359-368.
20. Fukumitsu N, Ogi S, Uchiyama M, Mori Y. Benzodiazepine effect of (125)Iiomazenil-benzodiazepine receptor binding and serum corticosterone level in a rat model. Nucl Med Biol 2005; 32: 95-100.
21. Knuth ED, Etgen AM. Corticosterone secretion induced by chronic isolation in neonatal rats is sexually dimorphic and accompanied by elevated ACTH. Horm Behav 2005; 47: 65-75.
22. Rentesi G, Antoniou K, Marselos M, Fotopoulos A, Alboycharali J, Konstandi M. Long-term consequences of early maternal deprivation in serotonergic activity and HPA function in adult rat. Neurosci Lett 2010; 480: 7-11.
23. Nicholson EK, Stock SR, Hamrick MW, Ravosa MJ. Biomineralization and adaptive plasticity of the temporomandibular joint in myostatin knockout mice. Arch Oral Biol 2006; 51: 37-49.
24. Odman A, Mavropoulos A, Kiliaridis S. Do masticatory functional changes influence the mandibular morphology in adult rats. Arch Oral Biol 2008; 53: 1149-1154.
25. Nicholson RA, Townsend DR, Gramling SE. Influence of a scheduled-waiting task on EMG reactivity and oral habits among facial pain patients and no-pain controls. Appl Psychophysiol Biofeedback 2000; 25: 203-219.
26. Cairns DM, Uchimura T, Kwon H, Lee PG, Seufert CR, Matzkin E, et al. Muscle cells enhance resistance to pro-inflammatory cytokine-induced cartilage destruction. Biochem Biophys Res Commun 2010; 392: 22-28.
27. Goldring MB, Birkhead JR, Suen LF, Yamin R, Mizuno S, Glowacki J, et al. Interleukin-1 beta-modulated gene expression in immortalized human chondrocytes. J Clin Invest 1994; 94: 2307-2316.
28. Kaneyama K, Segami N, Nishimura M, Suzuki T, Sato J. Importance of proinflammatory cytokines in synovial fluid from 121 joints with temporomandibular disorders. Br J Oral Maxillofac Surg 2002; 40: 418-423.
29. Nishimura M, Segami N, Kaneyama K, Suzuki T, Miyamaru M. Proinflammatory cytokines and arthroscopic findings of patients with internal derangement and osteoarthritis of the temporomandibular joint. Br J Oral Maxillofac Surg 2002; 40: 68-71.
30. Gulen H, Ataoglu H, Haliloglu S, Isik K. Proinflammatory cytokines in temporomandibular joint synovial fluid before and after arthrocentesis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009; 107: e1-e4.
31. Aida Y, Maeno M, Suzuki N, Namba A, Motohashi M, Matsumoto M, et al. The effect of IL-1beta on the expression of inflammatory cytokines and their receptors in human chondrocytes. Life Sci 2006; 79: 764-771.
32. Roman-Blas JA, Stokes DG, Jimenez SA. Modulation of TGF-beta signaling by proinflammatory cytokines in articular chondrocytes. Osteoarthritis Cartilage 2007; 15: 1367-1377.
33. Inanir A, Ozoran K, Tutkak H, Mermerci B. The effects of calcitriol therapy on serum interleukin-1, interleukin-6 and tumour necrosis factoralpha concentrations in postmenopausal patients with osteoporosis. J Int Med Res 2004; 32: 570-582.
34. Kay J, Calabrese L. The role of interleukin-1 in the pathogenesis of rheumatoid arthritis. Rheumatology 2004; 43 (Suppl 3): iii2-iii9.
35. Naguwa SM. Tumor necrosis factor inhibitor therapy for rheumatoid arthritis. Ann N Y Acad Sci 2005; 1051: 709-715.
36. Vernal R, Velasquez E, Gamonal J, Garcia-Sanz JA, Silva A, Sanz M. Expression of proinflammatory cytokines in osteoarthritis of the temporomandibular joint. Arch Oral Biol 2008; 53: 910-915.